[1] BOSCH X, POCH E, GRAU J M. Rhabdomyolysis and acute kidney injury[J]. N Engl J Med, 2009, 361(1): 62-72. [2] CABRAL B M I, EDDING S N, PORTOCARRERO J P, et al. Rhabdomyolysis[J]. Dis Mon, 2020, 66(8): 101015. [3] INFANTEB, FRANZIN R, MADIO D, et al. Molecular mechanisms of AKI in the elderly: from animal models to therapeutic intervention[J]. J Clin Med, 2020, 9(8): 2574. [4] CHANG-PANESSO M. Acute kidney injury and aging[J]. Pediatr Nephrol, 2021, 36(10): 2997-3006. [5] MICHELSEN J, CORDTZ J, LIBORIUSSEN L, et al. Prevention of rhabdomyolysis-induced acute kidney injury - A DASAIM/DSIT clinical practice guideline[J]. Acta Anaesthesiol Scand, 2019, 63(5): 576-586. [6] LEVEY A S, JAMES M T. Acute kidney injury[J]. Ann Intern Med, 2017, 167(9): ITC66-ITC80. [7] DANAEI B, SHARIFI A, MAZLOOM H, et al. Prevalence of compartment syndrome and disseminated intravascular coagulation following rhabdomyolysis; a systematic review and meta-analysis[J]. Arch Acad Emerg Med, 2023, 11(1): e55. [8] PETERMANN-ROCHAF, BALNTZI V, GRAY S R, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2022, 13(1): 86-99. [9] NAWARSKAS J J. HMG-CoA reductase inhibitors and coenzyme Q10[J]. Cardiol Rev, 2005, 13(2): 76-79. [10] BANDSCHAPP O, GIRARD T. Malignant hyperthermia[J]. Swiss Med Wkly, 2012, 142: w13652. [11] 高伟波, 朱继红. 横纹肌溶解症的诊治策略[J]. 疑难病杂志, 2011, 10(1): 77-79. [12] CHEN Y, KLEIN S L, GARIBALDI B T, et al. Aging in COVID-19: vulnerability, immunity and intervention[J]. Ageing Res Rev, 2021, 65: 101205. [13] GRIMBY G. Muscle performance and structure in the elderly as studied cross-sectionally and longitudinally[J]. J Gerontol A Biol Sci Med Sci, 1995, 50: 17-22. [14] PETEJOVA N, MARTINEK A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review[J]. Crit Care, 2014, 18(3): 224. [15] BAGLEY W H, YANG H, SHAH K H. Rhabdomyolysis[J]. Intern Emerg Med, 2007, 2(3): 210-218. [16] 陈曦, 邹琪, 张新超. 老年人横纹肌溶解症的临床特点及病因分析[J]. 中华老年医学杂志, 2021(1): 87-91. [17] DE MEIJER A R, FIKKERS B G, DE KEIJZER M H, et al. Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey[J]. Intensive Care Med, 2003, 29(7): 1121-1125. [18] REX N, MELK A, SCHMITT R. Cellular senescence and kidney aging[J]. Clin Sci: Lond, 2023, 137(24): 1805-1821. |